Clinical relevance of human papillomavirus testing in cytopathology

被引：34
作者：
Brink, AATP [1 ]
Zielinski, GD [1 ]
Steenbergen, RDM [1 ]
Snijders, PJF [1 ]
Meijer, CJLM [1 ]
机构：
[1] Vrije Univ Amsterdam, Ctr Med, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
来源：
CYTOPATHOLOGY | 2005年 / 16卷 / 01期
关键词：
human papillomavirus; cervical carcinoma; cervical intraepithelial neoplasia; cytology; screening;
D O I：
10.1111/j.1365-2303.2004.00227.x
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Cancer of the uterine cervix is the second most common cancer in women worldwide. Currently, cervical screening is based on cytology alone. Because infection with high-risk human papillomavirus types (hrHPVs) is a necessary cause of cervical cancer, it has been postulated that screening might become more efficient when it is based on combined cytology and hrHPV testing. In this review we will discuss the advantages of added HPV tests in cervical cancer screening, as a quality control for false-negative smears, in triage of women with equivocal smears, in follow-up of women treated for CIN3 or cervical cancer and for the detection of cervical adenocarcinoma.
引用
收藏
页码：7 / 12
页数：6
相关论文
共 57 条
  • [1] BERKHOF J, 2004, IN PRESS INT J CANC
  • [2] The causal relation between human papillomavirus and cervical cancer
    Bosch, FX
    Lorincz, A
    Muñoz, N
    Meijer, CJLM
    Shah, KV
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
  • [3] The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996
    Bulk, S
    van Kemenade, FJ
    Rozendaal, L
    Meijer, CJLM
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (04) : 388 - 393
  • [4] Pobascam, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women
    Bulkmans, NWJ
    Rozendaal, L
    Snijders, PJF
    Voorhorst, FJ
    Boeke, AJP
    Zandwijken, GRJ
    van Kemenade, FJ
    Verheijen, RHM
    von Groningen, K
    Boon, ME
    Keuning, HJF
    van Ballegooijen, M
    van den Brule, AJC
    Meijer, CJLM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (01) : 94 - 101
  • [5] Castle PE, 2002, CANCER EPIDEM BIOMAR, V11, P1394
  • [6] Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions
    Clavel, C
    Masure, M
    Putaud, I
    Thomas, I
    Bory, JP
    Gabriel, R
    Quereux, C
    Birembaut, P
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (10) : 737 - 740
  • [7] Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
    Clavel, C
    Masure, L
    Bory, JP
    Putaud, I
    Mangeonjean, C
    Lorenzato, M
    Nazeyrollas, P
    Gabriel, R
    Quereux, C
    Birembaut, P
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (12) : 1616 - 1623
  • [8] Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women
    Clavel, C
    Masure, M
    Bory, JP
    Putaud, I
    Mangeonjean, C
    Lorenzato, M
    Gabriel, R
    Quereux, C
    Birembaut, P
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (09) : 1306 - 1311
  • [9] Human papillomavirus type specific DNA and RNA persistence - Implications for cervical disease progression and monitoring
    Cuschieri, KS
    Whitley, MJ
    Cubie, HA
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (01) : 65 - 70
  • [10] Management of women who test positive for high-risk types of human papillomavirus: the HART study
    Cuzick, J
    Szarewski, A
    Cubie, H
    Hulman, G
    Kitchener, H
    Luesley, D
    McGoogan, E
    Menon, U
    Terry, G
    Edwards, R
    Brooks, C
    Desai, M
    Gie, C
    Ho, L
    Jacobs, I
    Pickles, C
    Sasieni, P
    [J]. LANCET, 2003, 362 (9399) : 1871 - 1876
123456